Scientists and clinicians at TRI are working towards improved diagnosis and treatment of various cancers including breast, prostate, head and neck, and skin cancers.

In 2018, an estimated 140,000 new cases of cancer were diagnosed, and just under 50,000 people died from the disease (AIHW, 2018). In Australia, the most commonly diagnosed cancers are currently breast cancer, followed by prostate cancer, colorectal cancer and melanoma.(AIHW, 2018

Researchers at TRI are working closely with clinicians to identify novel ways to detect, diagnose, monitor and treat various types of cancers. These projects include specialist cancer groups across QUT's Institute of Health and Biomedical Innovation, Mater Research, The University of Queensland.

Image: Cancer tumour spheroid with fluorescent labelling according to cell phenotype. Crystal Tonnessen (June 2015).

Key Researchers
Andrew Perkins
Nicholas Andrew Saunders
Colleen Nelson
Geoffrey Faulkner
Ingrid Winkler
Jean-Pierre Levesque
John Hooper
Judith Clements
Kristen Radford
Maher Gandhi
Show More ...
Click a program below to learn more
Blood Cancer
Breast Cancer
Cervical Cancer
Head and Neck Cancer
Kidney Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Interview with Prof John Hooper about pancreatic cancer research
EARLY WARNING SIGNAL FOR BREAST CANCER IN WOMEN WITH BRCA GENE Dr David Clark and Professor Carolyn Mountford in the HMRI Imaging Centre Australian researchers have developed a new magnetic resonance...Read more
Prostate cancer collaborative research symposium The Prostate Cancer Collaborative Research Symposium program will facilitate knowledge sharing and collaborative networking within the global prostate...Read more
tri cancer seminar Thursday, 11 December 2014 9:00am-10:00am, Room 2007, Level 2 Andy Wu (MRI) ‘Macrophage depletion influence woven bone formation in a murine model of prostate cancer...Read more
Final PhD Seminar by Ruth Fuhrman-Luck "Determining the kallikrein-related peptidase 4-regulated degradome and transcriptome in the prostate cancer microenvironment" Prostate cancer is a...Read more
Mushroom compound with Vit E suppress prostate cancer tumours Stopping Australia's most commonly diagnosed cancer - prostate cancer - in its tracks is the goal of scientists around the world. A...Read more
TRI Cancer Seminar Speakers: Fiona Simpson (UQDI) on 'Breast cancer, Herceptin and Girdin' and Gregor Tetz (QUT) on 'Co-targeting H2 relaxin and androgen signally in prostate cancer'.Read more
New gene research helps pinpoint prostate cancer risk Scientists could soon better predict a man's risk of getting prostate cancer after a worldwide team of researchers carried out the largest-...Read more
TRI Cancer Seminar Inga Mertens presents ‘Investigating downstream targets of EphB4 - Role of integrin β8 in prostate cancer’ Kristeen Tullet presentation TBC.Read more
TALENTED TRI-BASED RESEARCHERS RECOGNISED AT WOMEN IN TECHNOLOGY AWARDS The outstanding work of TRI researchers has been recognised with two winners at the 17th Annual Women in Technology (WiT)...Read more
prostate cancer drugs made more effective More than 20,000 Australian men are diagnosed with prostate cancer each year – and the disease kills 3,300 annually. “The death rate of men from...Read more